BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:EPFL BioE Talks SERIES  "Engineering T Cells to Target Hematologic
  Malignancies"
DTSTART:20210531T160000
DTEND:20210531T170000
DTSTAMP:20260511T165328Z
UID:ff7c0b2099164a41794653abec4158d555fa4095304a3decd57ae777
CATEGORIES:Conferences - Seminars
DESCRIPTION:Prof. Caroline Arber\, Department of Oncology\, University of 
 Lausanne (UNIL) and Lausanne University Hospital (CHUV)\; Ludwig Institut
 e for Cancer Research (LICR)\, Lausanne (CH)\nWEEKLY EPFL BIOE TALKS SERIE
 S\n\nAbstract:\nEngineered T cell therapies have profoundly impacted treat
 ment strategies and improved outcomes in patients with certain B cell mali
 gnancies. However\, early relapse and no response to treatment hampers bro
 ader success\, and applicability to other cancer types remains very limite
 d. The Arber lab develops novel engineering approaches for enhanced tumor 
 targeting\, and to counterbalance mechanisms of resistance to T cell thera
 py. Our engineering strategies are evaluated functionally in the context o
 f various cellular platforms with the goal to engineer cells that provide 
 long-term anti-tumor function and tumor immune surveillance\, and that hav
 e the capability to induce long term remissions.\n\nBio:\nCaroline Arber r
 eceived her Doctor of Medicine from the University of Basel\, Switzerland\
 , in 2000. After a research fellowship at Stanford University (2001-2003)\
 , she completed clinical specialization with FMH titles in both Internal M
 edicine and Hematology in Switzerland. Focusing on stem cell transplant an
 d cellular therapies\, she was attracted into the T cell engineering field
  and moved to Baylor College of Medicine\, USA. After a postdoctoral fello
 wship from 2010-2013\, she started her independent research as Assistant P
 rofessor in 2014. In 2017\, she was recruited to CHUV-UNIL-LICR Lausanne t
 o build a translational research program of targeted T cell therapies for 
 hematologic malignancies. At CHUV\, she leads the CAR T clinic for hematol
 ogic indications. Dr. Arber is the recipient of several awards\, including
  an American Society of Hematology Scholar Award (2013)\, a Leukemia and L
 ymphoma Society Translational Research Program Award (2015)\, and a Team S
 cience Recognition Award by the Society for Immunotherapy of Cancer (2020)
  to the Lausanne Branch of the Ludwig Institute for Cancer Research.\n\n\
 n\nZoom link (with registration) for attending remotely: https://go.epfl.c
 h/EPFLBioETalks\n\n\nIMPORTANT NOTICE: due to restrictions resulting from 
 the ongoing Covid-19 pandemic\, this seminar can be followed via Zoom web-
 streaming only\, (following prior one-time registration through the link a
 bove).
LOCATION:via Zoom web-streaming only\, due to Covid-19 pandemic https://go
 .epfl.ch/EPFLBioETalks https://go.epfl.ch/EPFLBioETalks
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR